Skip to main content
Log in

Lokalisiertes Prostatakarzinom

Wer profitiert von welchem lokalen Vorgehen?

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Wilt TJ et al. N Engl J Med. 2017;377(2):132–142.

    Article  Google Scholar 

  2. Bill-Axelson A et al. N Engl J Med. 2011;364(18):1708–17.

    Article  CAS  Google Scholar 

  3. Hamdy FC et al. N Engl J Med. 2016;375(15):1415–24.

    Article  Google Scholar 

  4. Warde P et al. Lancet. 2011;378(9809):2104–11.

    Article  Google Scholar 

  5. Widmark A et al. Lancet. 2009;373(9660):301–8.

    Article  CAS  Google Scholar 

  6. Bolla M et al. Lancet Oncol. 2010;11(11):1066–73.

    Article  CAS  Google Scholar 

  7. Fizazi K et al. Lancet Oncol. 2015;16(7):787–94.

    Article  CAS  Google Scholar 

  8. James ND et al. N Engl J Med. 2017;377(4):338–351.

    Article  CAS  Google Scholar 

  9. James ND et al. JAMA Oncol. 2016;2(3):348–57.

    Article  Google Scholar 

  10. Rusthoven CG et al. J Clin Oncol. 2016;34(24):2835–42.

    Article  CAS  Google Scholar 

  11. Donovan JL et al. N Engl J Med. 2016;375(15):1425–37.

    Article  CAS  Google Scholar 

  12. Resnick MJ et al. N Engl J Med. 2013;368(5):436–45.

    Article  CAS  Google Scholar 

  13. Erstpubliziert in Strahlenther Onkol. 2017;194(2):174-77.

  14. Wilt TJ et al. Follow-up of Prostatectomy versus Observation for Early Prostate Cancer. N Engl J Med. 2017; 377(2):132–42.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephanie Kroeze.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kroeze, S., Fritz, C. & Guckenberger, M. Wer profitiert von welchem lokalen Vorgehen?. Info Onkol. 21, 32–34 (2018). https://doi.org/10.1007/s15004-018-6095-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-018-6095-3

Navigation